Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (1724)	2/15/1999 1:44:00 PM
From: Dave Gore	Read Replies (1) \| Respond to of 2135

ANTHONY..... You know NONE of us won on ENMD the other day. The very best thing that could have happened is if that WSJ article didn't come out and we rode the stock to $35-50 or even $80 and THEN shorted it, and then have the WSJ article come out the next day. As it turns out now, this stock will hover in a fairly tight trading range until human testing results begin and results are announced....YAWN.... I only lost $150 because I bought ENMD right....cheap seminar....maybe I will come. Details?